Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Agios Pharmaceuticals Inc AGIO

Healthcare Biotechnology
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AGIO)

Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024

GlobeNewswire 8 days ago

Agios Publishes 2024 Environmental, Social and Governance (ESG) Report

GlobeNewswire April 9, 2024

Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024

GlobeNewswire March 5, 2024

Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

GlobeNewswire February 22, 2024

Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

GlobeNewswire February 15, 2024

Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024

GlobeNewswire February 2, 2024

Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio

GlobeNewswire January 8, 2024

Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia

GlobeNewswire January 3, 2024

Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

GlobeNewswire January 2, 2024
View More News ››

Opinion & Analysis (NDAQ:AGIO)

Biotech Stocks Sell Off, ETFs Fall Over 5%

Benzinga.com  December 23, 2014
View More Opinion ››

Bullboard Posts (NDAQ:AGIO)

5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS

$AGIO $CYTK $ADGI $PHAT $ICPT   Clinical-Stage companies offer an exciting investment opportunity with massive upside...
AviseAnalytics - February 8, 2022
View more Bullboard ››

North Arrow Minerals Inc.

North Arrow Minerals Inc.

North Arrow Minerals Inc. is a Canada-based exploration company. The Company is focused on the identification and evaluation ...
View More »